Invention Grant
- Patent Title: Benzodiazepine bromodomain inhibitor
- Patent Title (中): 苯二氮卓溴结构域抑制剂
-
Application No.: US13505039Application Date: 2010-08-06
-
Publication No.: US09023842B2Publication Date: 2015-05-05
- Inventor: Romain Luc Marie Gosmini , Olivier Mirguet
- Applicant: Romain Luc Marie Gosmini , Olivier Mirguet
- Applicant Address: US DE Wilmington, New Castle
- Assignee: GlaxoSmithKline LLC
- Current Assignee: GlaxoSmithKline LLC
- Current Assignee Address: US DE Wilmington, New Castle
- Agent Robert H. Brink
- Priority: GB0919433.3 20091105; GB1010509.6 20100622
- International Application: PCT/EP2010/061518 WO 20100806
- International Announcement: WO2011/054553 WO 20110512
- Main IPC: A61K31/55
- IPC: A61K31/55 ; C07D487/04
Abstract:
The present invention relates to a benzodiazepine compound of formula (I), processes for its preparation, pharmaceutical compositions containing such a compound and to its use in therapy.
Public/Granted literature
- US20120220573A1 Benzodiazepine Bromodomain Inhibitor Public/Granted day:2012-08-30
Information query
